Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
Feldman D, Cao D, Sartori S, Zhang Z, Hengstenberg C, Tron C, Anthopoulos P, Widder JD, Meneveau N, Stella PR, Ferrari M, Jeger R, Violini R, Dumonteil N, Chen S, Yan R, Nicolas J, Razuk V, Spirito A, Vogel B, Mehran R, Dangas G. Feldman D, et al. Among authors: stella pr. Catheter Cardiovasc Interv. 2023 May;101(6):1134-1143. doi: 10.1002/ccd.30647. Epub 2023 Apr 10. Catheter Cardiovasc Interv. 2023. PMID: 37036268 Clinical Trial.
A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
Stella PR, Belkacemi A, Dubois C, Nathoe H, Dens J, Naber C, Adriaenssens T, van Belle E, Doevendans P, Agostoni P. Stella PR, et al. Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1138-46. doi: 10.1002/ccd.23499. Epub 2012 Mar 15. Catheter Cardiovasc Interv. 2012. PMID: 22422607 Clinical Trial.
The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent.
Haude M, Lee SW, Worthley SG, Silber S, Verheye S, Erbs S, Rosli MA, Botelho R, Meredith I, Sim KH, Stella PR, Tan HC, Whitbourn R, Thambar S, Abizaid A, Koh TH, Den Heijer P, Parise H, Cristea E, Maehara A, Mehran R. Haude M, et al. Among authors: stella pr. JACC Cardiovasc Interv. 2013 Apr;6(4):334-43. doi: 10.1016/j.jcin.2012.10.018. Epub 2013 Mar 20. JACC Cardiovasc Interv. 2013. PMID: 23523459 Free article. Clinical Trial.
Angiographic fate of side branch dissections in bifurcation lesions treated with a provisional single stenting strategy: a post-hoc analysis of the international multicenter randomized DEBIUT study.
Belkacemi A, Stella PR, Chunlai S, Uiterwijk M, Ali D, Agostoni P. Belkacemi A, et al. Among authors: stella pr. Catheter Cardiovasc Interv. 2014 Mar 1;83(4):539-44. doi: 10.1002/ccd.25172. Epub 2013 Sep 30. Catheter Cardiovasc Interv. 2014. PMID: 24038817 Clinical Trial.
Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: the nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial.
Nijhoff F, Agostoni P, Belkacemi A, Nathoe HM, Voskuil M, Samim M, Doevendans PA, Stella PR. Nijhoff F, et al. Among authors: stella pr. Catheter Cardiovasc Interv. 2015 Oct;86 Suppl 1:S34-44. doi: 10.1002/ccd.26060. Epub 2015 Jun 29. Catheter Cardiovasc Interv. 2015. PMID: 26119971 Clinical Trial.
Outcomes of a dedicated stent in coronary bifurcations with large side branches: A subanalysis of the randomized TRYTON bifurcation study.
Généreux P, Kini A, Lesiak M, Kumsars I, Fontos G, Slagboom T, Ungi I, Metzger DC, Wykrzykowska JJ, Stella PR, Bartorelli AL, Fearon WF, Lefèvre T, Feldman RL, Tarantini G, Bettinger N, Minalu Ayele G, LaSalle L, Francese DP, Onuma Y, Grundeken MJ, Garcia-Garcia HM, Laak LL, Cutlip DE, Kaplan AV, Serruys PW, Leon MB. Généreux P, et al. Among authors: stella pr. Catheter Cardiovasc Interv. 2016 Jun;87(7):1231-41. doi: 10.1002/ccd.26240. Epub 2015 Sep 23. Catheter Cardiovasc Interv. 2016. PMID: 26397982 Clinical Trial.
Transcatheter Heart Valve Selection and Permanent Pacemaker Implantation in Patients With Pre-Existent Right Bundle Branch Block.
van Gils L, Tchetche D, Lhermusier T, Abawi M, Dumonteil N, Rodriguez Olivares R, Molina-Martin de Nicolas J, Stella PR, Carrié D, De Jaegere PP, Van Mieghem NM. van Gils L, et al. Among authors: stella pr. J Am Heart Assoc. 2017 Mar 3;6(3):e005028. doi: 10.1161/JAHA.116.005028. J Am Heart Assoc. 2017. PMID: 28258051 Free PMC article.
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
Linke A, Chandrasekhar J, Sartori S, Lefevre T, van Belle E, Schaefer U, Tchetche D, Sardella G, Webb J, Colombo A, Windecker S, Vogel B, Farhan S, Sorrentino S, Sharma M, Snyder C, Asgar A, Dumonteil N, Tamburino C, Hink U, Violini R, Stella P, Bernstein D, Deliargyris E, Hengstenberg C, Baber U, Mehran R, Anthopoulos P, Dangas G; BRAVO-3 Investigators. Linke A, et al. Catheter Cardiovasc Interv. 2017 Nov 15;90(6):1016-1026. doi: 10.1002/ccd.27154. Epub 2017 Jul 19. Catheter Cardiovasc Interv. 2017. PMID: 28498562 Clinical Trial.
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry.
Sardella G, Stella P, Chiarito M, Leone AM, Balian V, Prosperi F, Sorropago G, Mancone M, Calcagno S, Briguori C, Stefanini GG. Sardella G, et al. Catheter Cardiovasc Interv. 2018 Apr 1;91(5):884-891. doi: 10.1002/ccd.27187. Epub 2017 Jul 14. Catheter Cardiovasc Interv. 2018. PMID: 28707375
212 results